Clinical Study

Assessment Of Dha On Reducing Early Preterm Birth

Posted Date: May 15, 2019

  • Investigator: Emily Defranco
  • Specialties:
  • Type of Study: Drug

ADORE Trial (DHA)

Criteria:

-Between 12 And 20 Weeks Pregnant -Expected To Have A Healthy Pregnancy -Agree To Consume Study Dha -Will Be Delivering At Ucmc

Keywords:

Women's Health, Pregnancy, Vitamin

For More Information:

Morgan Bamberger
513-584-2585
bamberme@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.